$BBLR
Bubblr Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224018009 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $1.168K $1.504K
YoY Change
Cost Of Revenue $389.00 $622.00
YoY Change
Gross Profit $779.00 $882.00
YoY Change
Gross Profit Margin 66.7% 58.64%
Selling, General & Admin $315.4K $328.2K $328.8K
YoY Change -75.45% -0.16%
% of Gross Profit 40484.34% 37215.53%
Research & Development $49.77K $47.87K $39.15K
YoY Change -4.5% 22.25%
% of Gross Profit 6389.35% 5426.87%
Depreciation & Amortization $2.513K $2.502K $3.106K
YoY Change -19.09% -19.45% -26.45%
% of Gross Profit 322.59% 283.67%
Operating Expenses $717.3K $438.1K $202.0K
YoY Change -59.92% 116.94%
Operating Profit -$716.5K -$437.2K -$202.0K
YoY Change -59.97% 116.5%
Interest Expense $29.44K $3.592K $1.129K
YoY Change 4671.47% 218.16%
% of Operating Profit
Other Income/Expense, Net $42.03K -$23.62K -$52.38K
YoY Change -51.48% -54.89%
Pretax Income -$674.5K -$460.9K -$254.3K
YoY Change -60.4% 81.2%
Income Tax
% Of Pretax Income
Net Earnings -$674.5K -$460.9K -$254.3K
YoY Change -60.4% 81.2% -75.32%
Net Earnings / Revenue -57748.37% -30642.75%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 159.7M shares 159.7M shares 155.7M shares
Diluted Shares Outstanding 159.7M shares 159.7M shares 154.9M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $790.00 $950.00
YoY Change
Cash & Equivalents $789.00 $951.00 $35.12K
Short-Term Investments
Other Short-Term Assets $200.00 $200.00
YoY Change
Inventory
Prepaid Expenses
Receivables $6.240K
Other Receivables $5.785K $88.94K
Total Short-Term Assets $6.574K $89.89K $41.36K
YoY Change -50.38% 117.36%
LONG-TERM ASSETS
Property, Plant & Equipment $901.00 $2.349K $45.80K
YoY Change -97.95% -94.87%
Goodwill
YoY Change
Intangibles $1.109M $1.410M $32.46K
YoY Change -13.62% 4243.23%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.110M $1.412M $1.352M
YoY Change -16.4% 4.45%
TOTAL ASSETS
Total Short-Term Assets $6.574K $89.89K $41.36K
Total Long-Term Assets $1.110M $1.412M $1.352M
Total Assets $1.117M $1.502M $1.393M
YoY Change -16.74% 7.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $383.4K $398.4K $394.0K
YoY Change 97.6% 1.11%
Accrued Expenses $1.333M $1.106M $96.33K
YoY Change 59.71% 1048.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $285.7K $264.0K
YoY Change
Total Short-Term Liabilities $2.002M $1.768M $1.139M
YoY Change 11.53% 55.29%
LONG-TERM LIABILITIES
Long-Term Debt $549.1K $548.3K
YoY Change
Other Long-Term Liabilities $19.32K $40.37K
YoY Change
Total Long-Term Liabilities $568.4K $588.7K $814.9K
YoY Change -24.95% -27.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.002M $1.768M $1.139M
Total Long-Term Liabilities $568.4K $588.7K $814.9K
Total Liabilities $2.570M $2.357M $1.954M
YoY Change 0.7% 20.65%
SHAREHOLDERS EQUITY
Retained Earnings -$16.79M -$16.10M -$13.15M
YoY Change 12.87% 22.38%
Common Stock $1.597M $1.597M $1.559M
YoY Change 1.79% 2.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.453M -$855.2K -$560.5K
YoY Change
Total Liabilities & Shareholders Equity $1.117M $1.502M $1.393M
YoY Change -16.74% 7.8%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$674.5K -$460.9K -$254.3K
YoY Change -60.4% 81.2% -75.32%
Depreciation, Depletion And Amortization $2.513K $2.502K $3.106K
YoY Change -19.09% -19.45% -26.45%
Cash From Operating Activities -$12.85K -$118.2K -$158.4K
YoY Change -25.39% -60.83%
INVESTING ACTIVITIES
Capital Expenditures -$3.660K $15.57K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $16.96K
YoY Change
Cash From Investing Activities -$13.30K $1.394K -$11.14K
YoY Change -112.52% -4.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 43.85K $92.47K $203.1K
YoY Change -54.48% -49.2%
NET CHANGE
Cash From Operating Activities -12.85K -$118.2K -$158.4K
Cash From Investing Activities -13.30K $1.394K -$11.14K
Cash From Financing Activities 43.85K $92.47K $203.1K
Net Change In Cash 17.70K -$6.717K $2.582K
YoY Change -360.15% -91.54%
FREE CASH FLOW
Cash From Operating Activities -$12.85K -$118.2K -$158.4K
Capital Expenditures -$3.660K $15.57K
Free Cash Flow -$9.190K -$133.7K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
CY2024Q1 dei City Area Code
CityAreaCode
(646)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
814 7184
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2024Q1 BBLR Forfeit Of Restricted Stock Units
ForfeitOfRestrictedStockUnits
usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2024Q1 BBLR Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2024Q1 BBLR Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
CY2024Q1 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
159690447 shares
CY2024Q1 us-gaap Cash
Cash
951 usd
CY2023Q4 us-gaap Cash
Cash
7668 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
88937 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
87503 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
89888 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
95171 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2349 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31302 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1409681 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1456628 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
1412030 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1487930 usd
CY2024Q1 us-gaap Assets
Assets
1501918 usd
CY2023Q4 us-gaap Assets
Assets
1583101 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
398365 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
373606 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1106074 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
943007 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1768409 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1487471 usd
CY2024Q1 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
40367 usd
CY2023Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
39116 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
588708 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
591755 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2357117 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2079226 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159690447 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159690447 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159690447 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159690447 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1596904 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1596904 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13277905 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13168915 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16095315 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15612775 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
365306 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
350830 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-855199 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-496125 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1501918 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1583101 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1504 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
622 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
882 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
310068 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16289 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
8028 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
-225570 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18173 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
312463 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
53991 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
59627 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47865 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39152 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
438125 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
201961 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-437243 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-201961 usd
CY2024Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1478 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
98 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
3592 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1129 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9355 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1251 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-72519 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10904 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
21175 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23624 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-52375 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-460867 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-254336 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-460867 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-254336 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14476 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-19142 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14476 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19142 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-446391 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-273478 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159690447 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159690447 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154904171 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154904171 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
86277 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
285338 usd
CY2023Q1 BBLR Stock Issued During Period Value Forfeit Restrictive Stock Units
StockIssuedDuringPeriodValueForfeitRestrictiveStockUnits
-659052 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
22133 usd
CY2023Q1 BBLR Stock Issued During Period Value Preferred Shares Dividend
StockIssuedDuringPeriodValuePreferredSharesDividend
-21672 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-254336 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19142 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-560454 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-496125 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-496125 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
108990 usd
CY2024Q1 BBLR Stock Issued During Period Value Preferred Shares Dividend
StockIssuedDuringPeriodValuePreferredSharesDividend
-21673 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-460867 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14476 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-855199 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-855199 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-460867 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-254336 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
285338 usd
CY2023Q1 BBLR Forfeit Of Restricted Stock Units
ForfeitOfRestrictedStockUnits
-659052 usd
CY2024Q1 BBLR Vesting Of Deferred Stock Based Compensation
VestingOfDeferredStockBasedCompensation
-108990 usd
CY2024Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-1251 usd
CY2023Q1 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-72519 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-9355 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51489 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
56521 usd
CY2024Q1 us-gaap Depreciation
Depreciation
2502 usd
CY2023Q1 us-gaap Depreciation
Depreciation
3106 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2121 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3778 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
25674 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
336901 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
145563 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3156 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-118164 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-158381 usd
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15566 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11138 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16960 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1394 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11138 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
12611 usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
2430 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18228 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
105076 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
223777 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92465 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
203119 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17588 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-31018 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6717 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2582 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7668 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32533 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
951 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
35115 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
301 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
4774 usd
CY2024Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2019-10-22
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-446391 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16095315 usd
CY2024Q1 BBLR Working Capital
WorkingCapital
1678521 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zTlyde7DRFwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zsVDwWDskNf7">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
40367 usd
CY2023Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement
39116 usd
CY2024Q1 us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_849_eus-gaap--DerivativesReportingOfDerivativeActivity_zjsA4XMNleB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zDj9Op2n2OS4">Common Stock Purchase Warrants and Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5742236 shares
CY2024Q1 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2632 pure
CY2023Q1 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2341 pure
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
1.2199 pure
CY2024Q1 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2684 pure
CY2023Q1 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2152 pure
CY2023Q4 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.2447 pure
CY2024Q1 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
5210 usd
CY2023Q1 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
19142 usd
CY2024Q1 us-gaap Deposit Assets
DepositAssets
200 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
200 usd
CY2024Q1 BBLR Research And Development Other Receivables
ResearchAndDevelopmentOtherReceivables
79582 usd
CY2023Q4 BBLR Research And Development Other Receivables
ResearchAndDevelopmentOtherReceivables
80205 usd
CY2024Q1 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
9155 usd
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
7098 usd
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
88937 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
87503 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83116 usd
CY2024Q1 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
56556 usd
CY2024Q1 BBLR Effects Of Foreign Currency Translation Property Equipment
EffectsOfForeignCurrencyTranslationPropertyEquipment
-647 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25913 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51814 usd
CY2024Q1 us-gaap Depreciation
Depreciation
2502 usd
CY2024Q1 BBLR Accumulated Depreciation Depletion And Amortization Disposals
AccumulatedDepreciationDepletionAndAmortizationDisposals
30349 usd
CY2024Q1 BBLR Accumulated Depreciation Depletion And Amortization Foreign Currency Translation Adjustments
AccumulatedDepreciationDepletionAndAmortizationForeignCurrencyTranslationAdjustments
-403 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23564 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2349 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31302 usd
CY2024Q1 us-gaap Depreciation
Depreciation
2502 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
9317 usd
CY2024Q1 BBLR Finite Lived Trademarks Effects Of Currency Translation
FiniteLivedTrademarksEffectsOfCurrencyTranslation
-2088 usd
CY2023Q4 BBLR Finite Lived Trademarks Effects Of Currency Translation
FiniteLivedTrademarksEffectsOfCurrencyTranslation
-1804 usd
CY2024Q1 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
36700 usd
CY2023Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
36558 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3412769 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3412769 usd
CY2024Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
15566 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
-26183 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3402152 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3402152 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1956141 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1956141 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51489 usd
CY2024Q1 BBLR Finite Lived Intangible Assets Accumulated Amortization Effects Of Currency Translation
FiniteLivedIntangibleAssetsAccumulatedAmortizationEffectsOfCurrencyTranslation
-15159 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1992471 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1409681 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1456628 usd
CY2024Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
15566 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51489 usd
CY2024Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2024Q1 BBLR Director Fees
DirectorFees
120000 usd
CY2023Q4 BBLR Director Fees
DirectorFees
90000 usd
CY2024Q1 BBLR Dividends Payable
DividendsPayable
86688 usd
CY2023Q4 BBLR Dividends Payable
DividendsPayable
65016 usd
CY2024Q1 BBLR Other Accred Liabilities
OtherAccredLiabilities
49892 usd
CY2023Q4 BBLR Other Accred Liabilities
OtherAccredLiabilities
76945 usd
CY2024Q1 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
166986 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
166986 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
682508 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
544060 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1106074 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
943007 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1691 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2430 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
434060
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
550468 usd
CY2022Q3 BBLR Derivative Loss On Contract
DerivativeLossOnContract
28043 usd
CY2022Q3 us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
95768 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159690447 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159690447 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
159690447 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
159690447 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
CY2023Q4 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2023 BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M7D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
CY2024Q1 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2024Q1 BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M7D
CY2024Q1 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
2538101 shares
CY2024Q1 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
0.32
CY2024Q1 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Exercisable Weighted Average Remaining Contractual Term1
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1
P3Y6M7D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
2538101 shares
CY2024Q1 BBLR Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm
P3Y6M7D
CY2024Q1 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.32
CY2024Q1 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
2538101 shares
CY2024Q1 BBLR Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
0.32
CY2023Q2 BBLR Option Vest Description
OptionVestDescription
Company granted options for purchasing our Common stock to executives, management, and a non-executive director as consideration for time served. The Board of Directors determine the terms of the stock option grants that are consistent with our 2022 Equity Incentive Plan.
CY2023Q2 BBLR Option Grant Description
OptionGrantDescription
Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years.
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14400000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.1560
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14400000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.1560
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10788000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.1560
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P9Y3D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
2.21 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
14400000 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.1560
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
10788000 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.1560
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
3612000 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.1560
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14400000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10788000 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y3D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.1560
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.1614
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0.00 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0.00 usd
CY2024Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
108990 usd
CY2024Q1 BBLR Unrecognized Compensation Liability Current
UnrecognizedCompensationLiabilityCurrent
517783 usd

Files In Submission

Name View Source Status
0001493152-24-018009-index-headers.html Edgar Link pending
0001493152-24-018009-index.html Edgar Link pending
0001493152-24-018009.txt Edgar Link pending
0001493152-24-018009-xbrl.zip Edgar Link pending
bblr-20240331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
bblr-20240331_cal.xml Edgar Link unprocessable
bblr-20240331_def.xml Edgar Link unprocessable
bblr-20240331_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
bblr-20240331_pre.xml Edgar Link unprocessable